logo-loader
viewAllerGenis

AllerGenis aiming to change the way food allergies are diagnosed

AllerGenis CEO Jim Garner joined Proactive at the Biotech Showcase 2020 in San Francisco. The privately-held, Pennsylvania-based company develops data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Ceres Power eyes expansion following new Bosch deal

This month German engineering firm Bosch increased its stake in Ceres Power Holdings (LON:CWR) to around 18% from 4% following a share subscription, netting Ceres £38mln. It was Bosch that approached Ceres too, pinpointing Ceres steel fuel cell technology as potentially the best in the...

3 hours, 19 minutes ago

2 min read